UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease

Schofield, Christine; Chaudhuri, K Ray; Carroll, Camille; Sharma, Jagdish C; Pavese, Nicola; Evans, Jonathan; Foltynie, Thomas; ... Lees, Andrew; + view all (2022) Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease. Neurodegenerative Disease Management 10.2217/nmt-2021-0057. (In press). Green open access

[thumbnail of UK Optipark manuscript_submission_15Dec21 (1).pdf]
Preview
Text
UK Optipark manuscript_submission_15Dec21 (1).pdf - Accepted Version

Download (156kB) | Preview

Abstract

AIM: This subanalysis of the OPTIPARK study aimed to confirm the effectiveness and safety of opicapone in patients with Parkinson's disease and motor fluctuations in clinical practice specifically in the UK and to assess the impact of opicapone on treatment costs. METHODS: Patients received opicapone added to levodopa for 6 months. Clinical outcomes were assessed at 3 and 6 months and treatment costs at 6 months. RESULTS: Most patients' general condition improved at 3 months, with sustained improvements reported at 6 months. Opicapone improved motor and non-motor symptoms at both timepoints, was generally well tolerated and reduced total treatment costs by GBP 3719. CONCLUSION: Opicapone added to levodopa resulted in clinical improvements and reduced treatment costs across UK clinical practice.

Type: Article
Title: Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.2217/nmt-2021-0057
Publisher version: https://doi.org/10.2217/nmt-2021-0057
Language: English
Additional information: © 2022 Future Science Group. This work is licensed under the Creative Commons Attribution4.0 License. To view a copy of this license, visit (http://creativecommons.org/licenses/by/4.0/).
Keywords: Parkinson's disease, cost-saving, health economics, levodopa, motor fluctuations, opicapone
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/10146443
Downloads since deposit
46Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item